Atlas Trials

Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant

Clinical trial NCT00602446 · TERMINATED

Trial details

NCT number
NCT00602446
Sponsor
Masonic Cancer Center, University of Minnesota
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerIron OverloadLeukemiaLymphomaMultiple Myeloma and Plasma Cell NeoplasmMyelodysplastic SyndromesNeuroblastomaOvarian Cancer
Start date
2007-08-01
Primary completion
2009-09-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.